The endoplasmic reticulum (ER) is a critical site of protein, lipid, and glucose metabolism, lipoprotein secretion, and calcium homeostasis. Many of the sensing, metabolizing, and signaling mechanisms for these pathways exist within or on the ER membrane domain. Here, we review the cellular functions of ER, how perturbation of ER homeostasis contributes to metabolic dysregulation and potential causative mechanisms of ER stress in obesity, with a particular focus on lipids, metabolic adaptations of ER, and the maintenance of its membrane homeostasis. We also suggest a conceptual framework of metabolic roundabout to integrate key mechanisms of insulin resistance and metabolic diseases.
The endoplasmic reticulum (ER) is a critical site of protein, lipid, and glucose metabolism, lipoprotein secretion, and calcium homeostasis. Many of the sensing, metabolizing, and signaling mechanisms for these pathways exist within or on the ER membrane domain. Here, we review the cellular functions of ER, how perturbation of ER homeostasis contributes to metabolic dysregulation and potential causative mechanisms of ER stress in obesity, with a particular focus on lipids, metabolic adaptations of ER, and the maintenance of its membrane homeostasis. We also suggest a conceptual framework of metabolic roundabout to integrate key mechanisms of insulin resistance and metabolic diseases.
Meeting Metabolic Challenges: The Function of the Endoplasmic Reticulum Nutrient overload and chronic metabolic diseases are the hallmarks of the 21 st century's public health challenges. Intake of calories of all forms (lipids, proteins, and carbohydrates) demands an adaptive response from the metabolic networks. Chronic exposure to excessive or inappropriate nutrients places a heavy burden on adaptive responses that ultimately fail and cause a pattern of continuous, low-level inflammatory and stress responses, which we refer to as metaflammation, leading ultimately to the chronic metabolic diseases of modern life: obesity, diabetes, cardiovascular disease, and other associated metabolically driven pathologies (Gregor and Hotamisligil, 2011) . Interestingly, the detrimental effects of acute overnutrition are rarely toxic, but instead present a transient challenge that is often adequately met by the adaptive systems. Long-term exposure, however, leads to a gradual loss of metabolic homeostasis, and diseases emerge as consequences of chronic and incremental dysregulation of metabolism. Chronic disease systems then are defined by changes in both the quality and quantity of substrates utilized for metabolism and by the inability of the metabolic control mechanisms themselves to manage long-term exposures to nutrients.
Under both normal physiological fluctuations of nutrients and conditions of excess, the endoplasmic reticulum (ER) has a vital role in maintaining cellular and organismic metabolic homeostasis. As we will discuss in this article, the ER provides significant adaptive capacity to metabolism in managing the periodic cycles associated with feeding, fasting and other metabolic demands of limited duration. This organelle however, appears to be less capable of providing the necessary metabolic flexibility to manage chronic and escalating metabolic challenges, possibly due to a lack of selective pressures to develop such counter measures during much of its evolution. Thus, the ER represents both an evolutionary bottleneck leading to common chronic diseases and a valuable target area for their prevention and treatment. Several key biological functions of the ER with relevance to metabolic aspects of ER stress and the unfolded protein response pathways and their regulation upon exposure to acute, cyclic, and chronic metabolic stresses will be discussed in the following sections with a heavier focus on liver.
Protein Synthesis and Secretion
Protein biosynthesis is the most enriched and best characterized function of the rough ER . It is estimated that up to 75% proteins are synthesized on the ER and all membrane or secreted proteins that enter the secretary pathway undergo quality control for proper folding in the ER lumen (Andrews and Tata, 1971) . This is an extraordinary task, as millions of molecules are processed through the ER in seconds, especially in a highly synthetic organ like the liver, and close to 50% of newly synthesized proteins fail to assume their properly folded forms. This aspect of ER function has been extensively reviewed recently and will not be covered in detail (Braakman and Bulleid, 2011; Hebert and Molinari, 2007) . When ER is stressed with the presence of misfolded proteins, the unfolded protein response (UPR) is activated (Mori, 2000) . The canonical UPR response (discussed further below) aims to reduce protein synthesis, facilitate protein disposal, and enhance protein folding to mitigate stress. If these efforts fail, UPR can also trigger death responses. It is curious that despite having a rather robust and elegant adaptive system, ER still fails to establish a healthy equilibrium against chronic metabolic challenges. It is therefore possible that metabolic stress introduces unusual constraints for the adaptive capacity of the ER. For example, a proper ER response is dependent on efficient nutrient management and accurate metabolic control, and a dysfunctional ER, along with other signals, intersects with a variety of inflammatory and stress signaling networks that in the long run can also add insult to the ER injury. Here, we will discuss how ER responses intersect with metabolism with an emphasis on lipids, not to suggest a superiority for this aspect of ER biology but since this aspect of metabolism is often overlooked in the consideration of ER adaptive biology and constitute the main focus of this article.
Intermediary Lipid Metabolism
The overabundance of nutrients such as lipids in obesity and caloric surplus leads to aberrant lipid management and ectopic fat accumulation. This lipotoxicity is a fundamental component of metabolic disease and insulin resistance (Unger and Scherer, 2010; McGarry and Dobbins, 1999) . Lipid metabolism occurs primarily at the ER, where many of the enzymes involved in intermediary and complex lipid metabolism reside, giving the ER a central but under-investigated role in managing lipotoxicity. The primary mechanisms for managing lipid substrates at the ER are presented in Figure 1A . Among lipids, careful control of cholesterol levels is particularly important as cholesterol exerts a strong ordering effect on membranes through its hydrophobic interactions with the fatty acids present in phospholipids. Control of cellular cholesterol levels occurs at the ER through pathways that sense the level of cholesterol or cholesterol derivatives within the ER membrane itself and relay signals controlling cholesterol synthesis and clearance. The primary modes of cholesterol regulation at the ER include initiation of cholesterol synthesis via the SCAP/SREBP2 pathway under conditions of low ER cholesterol (Brown and Goldstein, 2009) , conversion of cholesterol to oxysterols and eventually bile acids (Russell, 2003) for excretion in bile, and the production of cholesterol esters, which can migrate out of the membrane into lipid droplets by virtue of their hydrophobic properties (Martin and Parton, 2006) . Given that cholesterol is an evolutionarily conserved building block and that it is critical to cell function, it is likely that other pathways exist for sensing cholesterol and triggering regulation of metabolism, but it is not yet clear how quantitatively important those pathways are for ER cholesterol homeostasis.
The composition of the intracellular fatty acid pool is also regulated by the ER in order to meet the basic cellular demands for synthesizing complex lipids with a broad variety of structures ( Figure 1B ). Like cholesterol, the fatty acid composition of aggregate lipid structures has a profound impact on the physical properties of cellular membranes. The tools for modifying the structure of fatty acids include desaturases, elongases, and b oxidation cycles. The desaturases and elongases occur mainly in the ER (Miyazaki and Ntambi, 2008) ; thus, the ER is a crucial site for maintaining all aspects of fatty acid and lipid homeostasis in cells. Additionally, the process of synthesizing fatty acids de novo is controlled at least in part by fatty acid sensing mechanisms within the ER via the feedback inhibition of the release of the transcription factor SREBP-1 (Horton, 2002) . In humans the majority of de novo lipogenesis takes place in the liver while adipose tissue de novo lipogenesis is suppressed (Shrago et al., 1971) . Consequently, human adipose tissue lipids are mainly derived from the accumulation and modification of diet and liver-produced fatty acids. This is a critical consideration in making correlative evaluations related to the total amount of de The depiction of lipid metabolism at the ER is not intended to be comprehensive, but to provide a representation of the key functionalities of the ER in synthesizing, modifying, and exporting lipids. (A) Key metabolic processes in cholesterol metabolism occurring at the ER include control of cholesterol synthesis via SREBP release and upregulation of cholesterol synthesis enzymes including HMG-CoA reductase (HMGR), oxidation of excess membrane cholesterol by Cyp7a, a key step in liberating cholesterol for bile acid production and secretion, and the acylation of cholesterol into cholesterol esters by acyl-CoA:acyltransferase (ACAT), which, like DGAT, creates a highly hydrophobic entity that seeds the formation of lipid droplets within the membrane phase. (B) Key activities in fatty acid metabolism include synthesis of saturated fatty acids (SFA) via fatty acid synthase (FAS) and their elongation and desaturation to longer-chain SFA and monounsaturated fatty acids (MUFA) by the long-chain elongase (LCE) and stearoyl-CoA desaturase (SCD), respectively. Synthesis of fatty acids is controlled by SREBP-1. Essential (polyunsaturated, PUFA) fatty acids are metabolized by desaturation and elongation of highly unsaturated fatty acids (HUFA) by desaturases (FADS) and elongases (ELOVL), respectively. (C) Key activities in the synthesis of glycerolipids including phospholipids (PL) and triglycerides (TG) include glycerol-3-phosphate acyltransferase (GPAT), which acylates the sn-1 position of glycerol-3-phosphate, acylglycerolphosphate acyltransferase (AGPAT), which acylates the sn-2 position, phosphatidic acid phosphohydrolase (PAPH), which forms diacylglycerol, the diacylglycerol choline/ethanolaminephosphotransferases (CEPT) which form either phosphatidylcholine or phosphatidylethanolamine from diacylglycerol, and monoacylglycerol acyltransferase (MGAT) or diacylcglycerol acyltransferase (DGAT) which can acylate diacylglycerol to form triacylglycerol. The formation of triacylated TG seed the formation of a nonpolar phase within the membrane domain, and this can grow and mature into either a lipid droplet or a VLDL particle. Other important phospholipid synthesis pathways exist at the ER but are not shown. novo lipogenic products in blood or tissues, as these products are strong indicators of hepatic lipogenesis. Glycerolipid Synthesis, Lipid Droplet Formation, and VLDL Assembly There are two primary forms of complex lipids in the endoplasmic reticulum: amphiphilic phospholipids and neutral lipids such as triglycerides and cholesterol esters ( Figure 1C ). Phospholipids are essential for the assembly of membranes and the vesicles that traffic proteins and other entities to the rest of the cell. Triglycerides and cholesterol esters are sinks for excess fatty acid and cholesterol, and by virtue of their hydrophobic nature, seed the formation of lipid droplets within the ER membrane (Martin and Parton, 2006; Farese and Walther, 2009) . The formation of lipid droplets protects the cell from accumulation of excess fatty acids and maintains the integrity of the ER membrane. However, it may also consume ER membranes during this process, although the significance of this biology to ER function is not known. The primary pathway for the syntheses of both phospholipids and triglycerides is the Kennedy pathway, which sequentially acylates glycerol phosphate to phospholipids or triglycerides and is largely present at the ER (Fagone and Jackowski, 2009) . Control of both the fatty acid composition and the phospholipid type distribution has important effects on membrane function (Sprong et al., 2001) . Notably, the assembly of lipid droplets for intracellular lipid storage requires a specific increase in the synthesis of phosphatidylcholine at the ER, potentially putting the balance of the ER membrane composition at risk (Krahmer et al., 2011) . Thus, lipid metabolism plays an important role in maintaining ER membrane function and its disturbance, even in small ways, can pose major challenges that lead to ER stress and metabolic dysfunction (Fu et al., 2011) .
The synthesis and compositional control of lipids in the ER also needs to be tightly coordinated with lipid trafficking and secretion. Hepatocytes and other cell types have the capacity to assemble and secrete ApoB-containing lipoproteins comprising ApoB, triglycerides, cholesterol esters, and phospholipids. In hepatocytes, lipoprotein secretion serves not only to deliver lipid to peripheral tissues but also to clear the hepatocyte of excess cholesterol and fatty acid. Interestingly, the use of the VLDL assembly mechanism to clear lipid comes at the cost of increasing protein synthesis and lipid metabolism demands on the ER, and the regulation of this process appears tightly linked to fatty acid metabolism (Caviglia et al., 2011; Ota et al., 2008) . Consequently, signaling networks integral to the UPR program are directly linked to lipogenic pathways and lipid secretion, to coordinate the metabolic needs of a recovering or adapting ER. It is also critical to mention that the biology of lipids is not limited to their properties as building blocks and substrates but also includes specific signaling molecules and hormones that control local and systemic metabolic responses, which will be discussed further in the following sections. Calcium Homeostasis Calcium and phosphate are two vital cellular signaling molecules. However, to prevent the formation of calcium phosphate precipitates, mechanisms have evolved to extrude the vast majority of calcium out of the cell. As a result, the ratio of intracellular calcium concentration to extracellular calcium concentration is maintained around 1:100,000 (10 nM versus 1 mM) (Clapham, 2007) . Cellular processes that constantly require high levels of calcium are compartmentalized into membraneenveloped organelles that include ER, mitochondria, Golgi body, and others, and they require dedicated pumps to maintain proper calcium concentrations. The calcium concentration in the ER is roughly 10,000 times higher than that in the cytosol (0.1 mM versus 10 nM), and this gradient is maintained by the active transport function of Sarco-/endoplasmic reticulum calcium ATPase (SERCA) (Moore et al., 1975) . Many ER chaperones and post-translational modification enzymes depend on calcium for proper function, and maintaining ER calcium stores is critical for proper protein production (Michalak et al., 2002) . Additionally, the maintenance of extremely low cytosolic calcium concentrations allows for a broad range of calcium-mediated signaling events, most of which involve the controlled and transient release of calcium from the ER (Berridge et al., 2003) . The function of calcium transporters and channels is also modulated by membrane lipid composition, protein-protein interaction, and a range of post-translational modifications (Traaseth et al., 2008; Li et al., 2009; Fu et al., 2011) . Therefore, ER provides a platform for the crosstalk of many cellular signaling pathways and metabolic regulatory events through calcium fluxes and metabolism (Verkhratsky, 2005) .
ER Stress and Its Contribution to Insulin Resistance and Diabetes
In the presence of misfolded proteins, ER initiates the unfolded protein response through the actions of cannonical sensors PERK, IRE1, and ATF6 in an attempt to restore ER homeostasis (Walter and Ron, 2011; Malhotra and Kaufman, 2007; Mori, 2000) . Collectively, these branches operate through suppression of protein synthesis, facilitation of protein degradation, and increase the availability of chaperones and, if all fails, can drive cells to apoptosis ( Figure 2A ). An important link that led to the concept of metabolic regulation by ER emerged from the recognition of its ability to regulate insulin action and glucose metabolism (Ozcan et al., 2004; Hotamisligil, 2010b) . Insulin is one of the primary anabolic hormones in the body, stimulating glucose and lipid uptake into the peripheral tissues and the synthesis of proteins, glycogen, and lipids therein. As the major cellular anabolic organelle, ER plays a critical role in insulin-induced synthetic and growth pathways and the eventual development of obesity under permissive environmental exposures as well as the emergence of metabolic disorders during the course of chronic over-nutrition and obesity (Hotamisligil, 2010b) . There are at least two mechanisms by which ER stress counters whole body insulin-dependent biological processes: tissue insulin resistance and b cell failure resulting in impaired insulin production. While, these are the main aspects discussed here, it is critical to recognize, however, that the ER's impact on metabolism goes beyond the boundaries of insulin to include direct actions on many metabolic pathways independent of this hormone, and beyond diabetes as metabolic disease.
ER Stress and Insulin Production
A robust ER function is paramount to b cell function and survival with or without insulin resistance. This is evident in both mice and man, where mutations in PERK result in permanent neonatal diabetes, such as the case in Wolcott-Rallison syndrome (Delé -pine et al., 2000). Similar observations have also supported the role of this branch of the UPR in b cell function in models where eIF2a phosphorylation is altered (Harding et al., 2001; Zhang et al., 2002) . In the presence of insulin resistance, b cells proliferate and secrete more insulin, which can account for up to 50% of total protein synthesis. When facing a constant demand of insulin in the context of obesity and insulin resistance, translational suppression by eIF2a, while compromising the synthetic capacity, may not be sufficient to alleviate ER stress if it is not accompanied by proper coordination of the other mitigating events, chief among them being the ER folding capacity. This state creates yet another challenge since constitutively activated chaperoning programs may also not be compatible with long-term cellular homeostasis (Trusina et al., 2008) , In fact, this is likely the case for most, if not all, chronic ER stress conditions. For example, while critical for the UPR, when chronically produced ATF6 can also negatively regulate insulin production by suppressing the transcription of the proinsulin gene (Seo et al., 2008) , and abnormal constitutive activation of ATF6 and XBP1 contributes to b cell dysfunction and death in Ins2 + /Akita pancreatic b cells (Nozaki et al., 2004) . Curiously, deletion of Xbp1 also diminishes islet function and survival . In other words, the chaperoning aspect of ER homeostasis is a double-edged knife and needs to be precisely regulated; too little or too much can both be dangerous. In addition to the molecules in canonical UPR responses, there are other mutations implicated in pancreatic dysfunction and diabetes in humans, such as the Wolfram Syndrome 1 (Wfs1) gene, which is induced by ER stress and regulates ER calcium homeostasis and survival pathways ( (A) Canonical UPR. Unfolded or misfolded proteins activate the three ER stress sensors (IRE1, PERK, and ATF6) by releasing them from BiP binding. IRE1 is a ribonuclease that splices and religates HAC1/Xbp1 transcripts for the synthesis of an active transcription factor to induce the expression of chaperones and lipid synthesis enzymes. PERK is a kinase that phosphorylates eIF2a and suppresses protein synthesis. ATF6 is a transcription factor that once released from ER will travel to the Golgi body, cleaved and translocated to the nucleus to activate the transcription of chaperone genes. Upon severe stress conditions, the synthesis of ATF4 is enhanced in an eIF2a phosphorylation independent manner that promotes apoptosis. (B) Contribution of UPR to both inflammatory and metabolic abnormalities in obesity. UPR activates JNK at least through three different mechanisms: PKR, IRE1/TRAF/ASK1, and PERK/CHOP/ERO1L/IP3R/CaMK. JNK promotes inflammation and apoptosis by phosphorylating and activating AP1 family of transcription factors. JNK also phosphorylates IRS molecules on serine residues and act as an important mediator of insulin resistance. UPR can also modulate gluconeogenesis and lipogenesis in multiple ways. First, the insulin resistance resulting from UPR prevents the inactivation of Foxo1 and its gluconeogenic program by insulin. Second, the nuclear form of ATF6 inhibits gluconeogenesis and lipogenesis, respectively, by binding to TORC2 and SREBP2. Third, the spliced form of Xbp1 can directly or indirectly (through SREBP1) activate lipogenesis program while inhibiting gluconeogenesis. Lastly, eIF2a phosphorylation leads to the synthesis of CHOP and the activation of lipogenesis programs through CEBPa/b. The sometimes opposing effects of UPR in regulating gluconeogenesis and lipogenesis are context dependent. The lipogenesis program in the obese liver also alters the membrane lipid composition of ER, inhibition of SERCA and propagation of ER stress. Abbreviations: IRE1, inositol required 1; PERK, PKR-like endoplasmic reticulum localized kinase; ATF6, activating transcription factor 6.
ER Stress and Insulin Resistance
Chronic ER stress is present in liver, b cells, brain, and adipose tissue in animal models of obesity (Ozcan et al., 2004; Nakatani et al., 2005) , as well as obese humans (Boden et al., 2008; Sharma et al., 2008; Gregor et al., 2009) , but not uniformly in skeletal muscle (Deldicque et al., 2011) . In humans, weight loss results in reversal of these stress indicators in adipose and liver tissues (Gregor et al., 2009) . Importantly, alleviation of ER stress by chemical or molecular chaperones improves metabolic control and insulin sensitivity in animal models (Ozcan et al., 2006; Kammoun et al., 2009; Ozawa et al., 2005) and, most importantly, in obese humans (Kars et al., 2010; Xiao et al., 2011) , indicating that ER dysfunction is a critical contributor to chronic metabolic deterioration. The mechanism by which ER stress impairs insulin action and metabolic control is complex and can occur at several levels to impair signal transduction and direct or indirect perturbation of specific metabolic responses. At the signaling level, several mechanisms integrate ER stress responses with inflammatory and stress signaling cascades. These include activation of JNK through doublestranded RNA-dependent protein kinase (PKR) (Nakamura et al., 2010) , via the IRE1/TRAF2/ASK1 (Urano et al., 2000) or the PERK/CHOP/ERO1L/IP3R/CaMK (Timmins et al., 2009) pathways, all of which result in impaired insulin receptor signaling (Hirosumi et al., 2002; Ozcan et al., 2004; Sabio and Davis, 2010) (Figure 2B ). Genetic inhibition of certain aspects of IRE-1 activity by Bax-inhibitor 1 in the liver tissue also protects mice against insulin resistance and glucose intolerance (BaillyMaitre et al., 2010) . Interestingly, PKR is also induced by ER stress and required for JNK activation (Nakamura et al., 2010) in cells and whole animals upon short-or long-term exposure to lipids. PKR forms complexes with insulin receptor signaling components, inflammatory signaling molecules, and protein translation machinery, thereby integrating many metabolic and stress signals (Nakamura et al., 2010) . An intriguing possibility remains that PKR may directly sense a metabolic signal and serve to assemble a metaflammatory complex that is in play in metabolic regulation. Other possibilities linking ER function to metabolic control include alteration of the overall metabolic context that indirectly contributes to impaired insulin action through suppressing the secretion of metabolically favorable hormones such as adiponectin or promote the release of deleterious ones (Xu et al., 2010) or actions through the networks between liver and other metabolic organs with the central nervous system (Purkayastha et al., 2011) . Finally, endocrine functions of gut and the gut microbiota, which have profound effects on systemic metabolic homeostasis and pathological outcomes, also are regulated by ER stress and related inflammatory signaling pathways (Caricilli et al., 2011; Kau et al., 2011) .
Independent Metabolic Functions
As mentioned before, metabolism in general and glucose and lipid metabolism in particular could also be regulated through molecules involved in ER adaptive responses, independent of insulin action or even ER stress, in a classic sense ( Figure 2B ). ATF6 can inhibit the expression of gluconeogenic and lipogenic genes by binding to TORC2 and SREBP2, respectively, and suppress their function (Wang et al., 2009; Zeng et al., 2004) . XBP1 (and its yeast homolog, HAC1), as a transcription factor in its own right, directly regulates the expression of a large set of lipid metabolism genes and hyperactivation promotes hepatic steatosis (Lee et al., 2008; Acosta-Alvear et al., 2007) . XBP1has also been suggested to suppress hepatic gluconeogenesis by retaining Foxo1 in the cytosol independent of its own transcription activation function (Zhou et al., 2011) . Interestingly, deletion of Xbp1 in the liver was also found to prevent steatosis and hepatic insulin resistance (Jurczak et al., 2011) . Lastly, the UPR branch traditionally considered as the translational arm, PERK/eIF2a phosphorylation, also controls lipogenesis through CEBP/a, PPARg, and SREBP1 (Bobrovnikova-Marjon et al., 2008) . For example, PERK regulates the processing and maturation of SREBP and its target gene expression in the mammary gland (Bobrovnikova-Marjon et al., 2008) . Hence, there are multiple direct paths to metabolic regulation from UPR and the related inflammatory and stress signaling pathways independent of insulin action ( Figure 2B ).
Mechanisms of ER Stress in a Metabolic
Setting and the Role of Lipotoxicity ER stress can be envisioned to proceed in three modes: acute, periodic, and chronic ( Figure 3A) . The acute form of ER stress has been extensively studied and is typically induced by treatment with chemicals (e.g., tunicamycin, DTT, calcium ionophores, thapsigargin, saturated fatty acids, and cholesterol) that induce ER stress. The periodic mode of ER stress is largely associated with rhythmic or transient physiological activities (e.g., feeding-fasting cycles) (Pfaffenbach et al., 2010) or transient infusions of glucose or lipids (Boden et al., 2011) , and ER homeostasis is fully restored after each cycle. Just like acute inflammation, UPR in this context is an essential part of homeostasis. Chronic ER stress, however, is characterized by a state in which ER homeostasis is not fully restored during periodic cycles, either due to the continuous presence of a pre-existing ER stress inducer or the engagement of UPR in a vicious cycle, the byproducts of which also compromise ER function.
Chronic ER stress is the mode most relevant to metabolic health in the condition of nutrient excess, obesity, and insulin resistance. In recent years, a number of models have been developed that may explain ER dysfunction and stress in a metabolic context (Hotamisligil, 2010a; Tabas and Ron, 2011; Eizirik and Cnop, 2010) (Figure 3B ). Among mechanistic postulates inducing ER stress in obesity are protein misfolding by inhibition of protein N-glycosylation after fructose feeding (Qiu et al., 2005) , protein overload due to increased synthesis of insulin, apoB, or acute phase proteins or antibodies in the pancreas or liver of obese subjects (Su et al., 2009; Matveyenko et al., 2009) , lipid synthesis (Fu et al., 2011) or overload leading to the production of toxic lipid species (Samuel et al., 2010; Summers, 2006; Turpin et al., 2006) , or the disruption of membrane structure and inhibition of membrane protein function (Borradaile et al., 2006; Li et al., 2004) , inflammation reducing membrane, and chaperone protein function (Uehara et al., 2006; Nakamura et al., 2010) , and defective autophagy . The exact mechanism of chronic metabolic ER stress is likely to be tissue specific and context dependent and may involve the contribution of multiple pathways. For the purposes of this manuscript, particular interest will be paid to lipid-induced stress pathways and their connection to the induction of canonical ER Cell Metabolism 15, May 2, 2012 ª2012 Elsevier Inc. 627 stress. Again, this is not to suggest the relative importance over others but to provide a thorough examination of this aspect.
Acute ER Stress Induction by Lipids
The role of the saturated fatty acid palmitate (16:0), on metabolic disorders is widely acknowledged. For example, increased consumption or elevated blood levels of saturated fatty acids are associated with insulin resistance and the risk of diabetes in humans (Xiao et al., 2006; Hu et al., 2001; Wang et al., 2003; Vessby, 2000) . This effect has been recapitulated in experimental models, where treatment of cells or animals with palmitate induces acute ER stress and cytotoxicity (Borradaile et al., 2006; Wei et al., 2006; Erbay et al., 2009) . This is likely because palmitate does not effectively activate triglyceride synthesis (Lee et al., 2010) , and thus it can not be effectively sequestered into triglycerides unless unsaturated fatty acids are simultaneously present or other countermeasures can be deployed (Listenberger et al., 2003) . Consequently, palmitate may be metabolized to species that induce cytotoxicity: ceramides (Holland et al., 2007; Unger, 2002) , diacylglycerides (Samuel et al., 2010) , reactive oxygen species (Listenberger et al., 2001) , and highly saturated ER membrane phospholipids (Ariyama et al., 2010) .
Excess cholesterol can also induce acute ER stress. Cholesterol concentrations in the ER are kept exceedingly low through ER-resident mechanisms (Lange and Steck, 2008) . The reason for the maintenance of low concentrations of cholesterol in the ER is not entirely clear, but conditions that elevate ER cholesterol lead to ER stress and loss of SERCA-mediated calcium homeostasis, presumably by promoting the formation of an ordered ER membrane phase that perturbs SERCA structure (Feng et al., 2003) . Preventing externally loaded cholesterol from cycling to the ER via inhibitors of cholesterol transport prevents cholesterol-induced ER stress and cytotoxicity (Feng et al., 2003) . Cholesterol and palmitate can act additively to elicit cytoxicity, but it is not known whether the effect is a result of a synergistic membrane ordering effect, or by other additive biochemical and molecular mechanisms (Pineau et al., 2009) .
Unsaturated fatty acids including oleate and palmitoleate effectively prevent acute ER stress induction under conditions of either excess palmitate or cholesterol (Pineau et al., 2009; Listenberger et al., 2003; Peng et al., 2011) . The reasons for this in acute stress have to do with the ability of monounsaturated fatty acids to support adaptive mechanisms including triglyceride A) Conceptual models for three modes of ER stress induction with relevance to overnutrition and chronic disease. Periodic or adaptive UPR, typified by changes in ER homeostasis during feeding/fasting cycles, or other transient rhythmic demands, and represented by the black line. In such cases, substrate overflow and protein synthesis demands challenge the ER, but UPR and metabolic adaptations such as insulin resistance serve as mechanisms for restoring ER status. Acute nutrient-induced UPR and ER stress shown in the red line. This stress is typified by treatments that perturb the ER membrane composition or functionality directly, such as excess palmitate, cholesterol or chemicals such as tunicamycin. The relevance of this mode of ER stress to physiology is questionable, but many of the experimental protocols for the induction of ER stress follow this model. Chronic ER stress and loss of adaptive capacity, shown in blue and typified by long term overexposure to nutrients as in obesity. Under such conditions the ER does not have time, means, or capacity to fully restore functionality before facing another round of substrate supply and demand for synthesis. Hence, the ER progressively loses control over metabolism and its own membrane and folding homeostasis, leading to pathological states. (B) Factors influencing ER homeostasis and ER stress. Diet, excess caloric intake, and obesity are prime factors in taxing ER's homeostatic mechanisms and capacity. In particular, saturated fat and cholesterol (1), when provided in excess, can promote the formation of an ordered membrane domain in the ER that inhibits VLDL formation and SERCA activity, causing a loss of both lipid clearance and calcium homeostatic capabilities. Additionally, saturated fatty acids increase ApoB production demands, but are not good substrates for triglyceride synthesis, and inhibit the clearance of lipid from the ER membrane via lipid droplet formation -and may increase the production of lipotoxic mediators such as ceramides and DAG. Fructose and hyperglycemia (2) can impair normal protein glycosylation or activate lipogenesis and perturb membrane properties, leading to UPR. Inflammatory signals (3) increases demand on hepatic ER for the synthesis and secretion of acute phase proteins, inhibits SERCA activity, and may compromise UPR. Oxidative stress (4) resulting from nutrient overload or mitochondrial dysfunction can impair SERCA and ER chaperone function.
synthesis (Lee et al., 2010; Listenberger et al., 2003) . Genetic inhibition of the endogenous ability to convert saturated fatty acids to unsaturated fatty acids promotes ER stress in cells and animals (Green and Olson, 2011; Flowers et al., 2008) . In fact, it is feasible to postulate that products of de novo lipogenesis such as palmitoleate act to mitigate the potential damaging effects of saturated fatty acids that, when present in isolation, disrupt metabolism (Cao et al., 2008; Riquelme et al., 2011) . Chronic ER Stress Induction by Lipids While monounsaturated fatty acids are established attenuators of acute palmitate-induced ER stress, excess fatty acid exposure over long periods of time can exceed the capacity, especially of nonadipose cells, to maintain homeostasis, resulting in chronic ER stress and lipotoxicity. For example, short-term treatment of cells with oleic acid increases VLDL and triglyceride secretion, whereas extended incubation of cells with oleic acid can lead to ER stress and suppression of VLDL secretion (Ota et al., 2008) . Importantly, VLDL secretion and ER homeostasis under conditions of chronic oleate exposure can be restored in vivo and in vitro by PBA-a chemical chaperone, demonstrating that the chronic effects of fatty acids on ER function are related to compromised chaperone function and more importantly could be remedied by interventions targeting ER function (Ota et al., 2008) . Likewise PBA alleviates lipid-induced insulin resistance and b cell dysfunction in humans (Xiao et al., 2011) , although effects of PBA on systems unrelated to its chaperone role cannot be ruled out in either setting. Animal models with increased fatty acid desaturation capacity in extrahepatic sites are resistant to ER stress and the development of metabolic abnormalities associated with obesity (Cao et al., 2008; Erbay et al., 2009; Green and Olson, 2011) . For example, macrophages lacking the lipid binding protein aP2 strongly upregulate Scd1 expression, produce copious amounts of palmitoleate, and become resistant to palmitate-induced ER stress (Erbay et al., 2009) . Adipose and liver tissues of mice with high levels of palmitoleate are also devoid of the hallmarks of metabolic disease commonly found in dyslipidemic or obese mice, consistent with a protective role for MUFA accumulation (Cao et al., 2008) . In these cases, the source of palmitoleate was extrahepatic, allowing the detection of the biology independent of hepatic lipogenesis. In free-living humans, overall levels of palmitoleate in blood are dictated by rates of hepatic lipogenesis, and therefore total blood palmitoleate may be associated with metabolic risk and increased adiposity (Wang et al., 2003; Paillard et al., 2008; Navina et al., 2011) . Under conditions where palmitoleate is increased in a way that is dissociated from hepatic lipogenesis, we and others have noted its beneficial effects (Cao et al., 2008; Yang et al., 2011; Matsuzaka et al., 2007; Stefan et al., 2010; Mozaffarian et al., 2010) . In any case, the stress-mitigating and cytoprotective mechanisms of unsaturated fatty acids may be of great importance in understanding ER function and designing novel strategies for the prevention or treatment of diabetes and atherosclerosis. While there are many seemingly competing theories on which particular lipid species is directly responsible for the acute effects of palmitate (Samuel et al., 2010; Ussher et al., 2010; Holland et al., 2007) , the chronic induction of ER stress may in fact result from many simultaneous insults and respond to many remedies such as reductions in lipid exposure as a result of caloric restriction, weight loss, and genetic inhibition of intracellular fatty acid trafficking and signaling (Tsutsumi et al., 2011; Gregor et al., 2009; Erbay et al., 2009) .
Obesity induces a chronic state of ER stress in mice and humans (Hotamisligil, 2010b) , and it is reasonable to presume that the mechanism relates, at least in part, to a long-term exposure to lipids. An emerging line of evidence indicates that chronic ER stress in the liver may be related to subtle alterations in the phospholipid composition of the ER (Fu et al., 2011) . Even with triglyceride and cholesterol ester synthesis capacity intact (preventing acute induction of stress by fatty acids) long-term exposure to lipids can induce the formation of lipid droplets. These growing droplets require increased synthesis of phosphatidylcholine at the ER (Krahmer et al., 2011) . In studies systematically examining hepatic lipid metabolism, we have recently shown that an imbalance in the phosphatidylcholine/phosphatidylethanolamine concentrations in the ER from obese mice is related to altered SERCA function (Fu et al., 2011) . Inhibition of PEMT, an ER enzyme that converts the endofacial phospholipid phosphatidylethanolamine to the exofacial phosphatidylcholine, reversed obesity-driven changes in ER membrane composition and corrected SERCA dysfunction, ER stress, and abnormal glucose metabolism (Fu et al., 2011) . It is also worth noting that lipids and fatty acids have a vast array of physical forms that lead to a variety of functions in diverse lipid pools and their influence may involve other pathways. Indeed, a recent study highlighted the ability of the highly unsaturated fatty acid DHA to induce autophagy (Caviglia et al., 2011) , providing perhaps another mechanism for the maintenance of ER homeostasis . Lipids can also engage inflammatory pathways directly, although the molecular mediators and the lipid species involved are not yet established (Wen et al., 2011; Nakamura et al., 2010) . Considerably more research is necessary, especially in the specific signaling pathways and functional networks engaged by specific lipids in the future.
Integration of Stress, Insulin Resistance, and Lipid Metabolic Pathways
There are currently a number of models put forward to explain the mechanistic linkages among obesity, ER stress, insulin resistance, and type 2 diabetes. These include chronic ''metabolic'' inflammation or metaflammation characterized by altered production of adipokines/cytokines and the infiltration of immune cells into tissues (Gregor and Hotamisligil, 2011; Olefsky and Glass, 2010; Shoelson et al., 2006; Lumeng and Saltiel, 2011) , lipotoxicity and ectopic fat accumulation in the liver and perhaps skeletal muscle (Larson-Meyer et al., 2011; Savage et al., 2007) , and decreased mitochondrial function (Bournat and Brown, 2010; Muoio and Newgard, 2008) . These pathways have for the most part been studied as independent mechanisms for the induction of insulin resistance. Exploring these mechanisms in isolation has been extremely useful in simplifying initial experimental approaches; however, the results of these experiments have led to competing reductionist and compartmentalized proposals for the central mechanisms of insulin resistance. Interpreting these conflicting proposals is logically challenging, and more integrative interpretations will likely be necessary. The interconnectedness of metabolism as well as ER pathways makes it possible to assign the causation of insulin resistance The observations listed above suggest that the pathways leading to metabolic dysfunction are not structured in conventional linear and hierarchical networks. Instead, we propose that independent mechanisms for managing insulin signaling and metabolism may resemble the flow of traffic in a roundabout, so that individual pathways feed into and interact in a common conduit (Figure 4) . Such an arrangement of pathways for regulating hormone action and metabolism provides a framework for how individual or collective stresses may provide stimulus to induce insulin resistance (or other metabolic outcomes), just as evident in the quantized nature of traffic in a roundabout. A small but concerted increase in traffic from all input pathways is capable of stopping flow and disrupting function (i.e., insulin resistance), but so is an acute level of traffic from any one contributing pathway, or even a single blockage. As traffic jams may be propagated if not resolved promptly, initial impairment of singular metabolic functions may lead to chronic activation of additional insulin resistance pathways, and the deterioration of metabolic status, i.e., development of diabetes. In this flow of carbon and energy the roads are all connected and traffic can be rerouted. Impairments can be relieved without addressing all or even any of the original causes, either by identifying new exits (qualitative) or enhancing existing roadways (quantitative) (Figure 4) . As a qualitative example, the presence of unsaturated fatty acids can reroute the metabolism of saturated fatty acids and cholesterol toward storage or excretion (in the forms of triglyceride or cholesterol ester-rich lipid droplets and lipoproteins) and prevent insulin resistance, without the need to lower the amount of saturated fatty acids or cholesterol entering into the system. On the quantitative side, enhancement of ER function by chemical or molecular chaperones can facilitate lipoprotein assembly and excretion and concurrently reduce fatty acid loading into the roundabout by suppressing de novo lipogenesis (Ota et al., 2008) . Similar interconnectedness also exists for inflammatory responses, and resolution of this state, in the appropriate manner, can also liberate the congestion at the roundabout and improve metabolism (Figure 4) . This roundabout concept is consistent with other proposed models of insulin resistance including a prevalent hypothesis of mitochondrial dysfunction involving the accumulation of incompletely oxidized medium chain acylcarnitines (Muoio and Newgard, 2008) . A very important implication of the coordination and rerouting property of the roundabout structure is that, it permits the separation of cause and effect under certain conditions and confounds simplistic inference of causality from genetic studies, which are the foundation of many competing An overview of the metabolic roundabout. The metabolic roundabout regulates the flow of key metabolic species (vehicles). The level of any individual metabolite is regulated by a network of metabolic pathways (denoted by orange and green arrows respectively). The ability of an effector (such as insulin) to facilitate the flow of all metabolites entering the roundabout is constrained by the homeostatic balance (entrance/ exit) of each individual metabolite. Blockages or constrictions of any specific pathway linked to the metabolic circle will inevitably impair the flow of other connected metabolic pathways. Nutrient overabundance -induced traffic jams in the roundabout can be improved by (1) limiting the overall inflow of traffic or increasing the number of lanes (dashed orange arrow), (2) rerouting of traffic through secondary pathways (dashed black arrow), or, best of all, (3) repairing the initially deranged pathway (broken vehicle). The metabolites represented in the metabolic roundabout can be lipids, inflammatory mediators, neuronal signals and organelle components, and their sources can be dietary, cellular and even gut microbiota-derived. In the case of lipids, they could be recognized or uptaken by receptors, transporters and cellular organelles, and consequently trigger metaflammation, ER stress, and mitochondrial dysfunction. The activation of chronic inflammation and impairment of ER and mitochondria function can feed-forward contribute to further deterioration of the aberrant lipid profile by reducing fatty acid oxidation, promoting lipolysis, and stimulating de novo lipogenesis. Inflammatory mediators can promote lipogenesis, impair mitochondrial respiratory chain function (NO), and downregulate SERCA expression. Aberrant lipid profiles, impaired mitochondrial function and ER stress, in return, can promote metaflammation. Lastly, ER stress activates inflammatory cascades (JNK/IKK/CREB pathways), generates ROS, leads to mitochondrial calcium overload, and activates lipogenesis. Mitochondrial dysfunction, oxidative stress, metaflammation and lipogenesis further exacerbate ER stress by impairing protein folding (ROS from mitochondria), protein overloading (acute phase proteins of inflammation) and lipid overloading (lipogenesis). Hence, lipid metabolism, chronic inflammation, and ER stress can all initiate and resolve the problems at the metabolic roundabout when appropriately regulated temporally and spatially.
hypotheses of lipotoxicity and insulin resistance. Thus, integrated, systems-oriented approaches will be necessary in the future, not only for modeling and examining the contribution of individual pathways of insulin resistance and interactions between mechanistic platforms, but also for evaluating the efficacy of therapeutics in different tissues and pathological conditions.
The lipid-centric presentation of this concept here is not to implicate a diminished significance for glucose and/or amino acid metabolism in the pathogenesis of diabetes and metabolic syndrome or the interactive nature of pathways involving these aspects of metabolism. The metabolism of glucose, lipids, and amino acids are intimately coupled: both the carbon backbone and the reducing equivalents are passed along among metabolite classes, hence they too can be readily integrated into this proposal (Figure 4 ). It is conceivable that the ''traffic components'' in such a roundabout will not be limited to just metabolites, but also include mediators of inflammation, functional components of cellular organelles, and possibly other elements such as the input from gut. The exact composition of this metabolic roundabout may vary among different tissues at different disease states due to their differences in metabolic wiring, associated energy balance state, and duration of the stimulus. For example, promoting de novo lipogenesis in adipose tissue providing metabolic benefit (Cao et al., 2008) in contrast to the established detrimental effects of lipogenesis in liver and peripheral tissues. Similarly, inflammation enhances short-term mitochondrial function in the muscle and alters energy expenditure, while causing insulin resistance in the liver and adipose tissues and permanent tissue damage (Thaler et al., 2012) . Features and consequences of ER stress also differ between metabolic tissues. For example, patterns of ER stress in skeletal muscle do not resemble those observed in adipose tissue (Ozcan et al., 2004; Deldicque et al., 2010 Deldicque et al., , 2011 . Therefore, the roundabout organization of insulin resistance pathways provides a versatile but simple framework for disruptive, vicious-cycle-like propagation of chronic disease conditions including diabetes.
Concluding Remarks
Metabolism requires integration of many signals to manage carbon sources and maintain homeostasis. The fundamental nature of insulin resistance and metabolic diseases may therefore represent an entangled, metastable state of cellular and whole-body metabolism that is resistant to the anabolic action of insulin as well as other hormones, rather than the perturbation of individual metabolic or signaling pathways. It is also clear that not every aspect of metabolism is directly targeted by insulin or disrupted by insulin resistance. Perturbations in the central nervous system also play important roles in the pathogenesis of metabolic diseases and inflammation (Gautron and Elmquist, 2011; Lumeng and Saltiel, 2011) . Finally, the composition of the gut flora can exert an enormous influence on systemic metabolic outcomes and at times override the genetic and dietary impact on disease manifestation (Kau et al., 2011) . For this reason, the mechanism of ER stress in the pathogenesis of abnormal insulin action and diabetes shall be understood through the metabolic action of ER and its role as the primary organelle of cellular anabolic metabolism and a signal-integrating platform, so as other mechanisms regulating systemic metabolic homeostasis (Figure 4) . Opportunities therefore exist to exploit mechanisms relating to ER management of debilitating substrate flow for disease prevention or treatment. If this flow is not interrupted or diverted, overwhelming the ER structure and functional capacity initiates a vicious cycle of stress, degradation in metabolic control, modification of the ER membrane itself and a worsening of ER stress and functionality. We suggest that lipids play a unique and crucial role in this cycle because they are both regulated by the ER and comprise the ER membrane itself. The notion that increased capacity to cope with lipid overload spares ER functionality is consistent with findings from genetic experiments showing that by modifying the membrane phospholipid composition (Fu et al., 2011) , promoting the clearance of lipotoxic substrate (Listenberger et al., 2003; Flowers et al., 2008) , or by preventing the presentation of lipotoxic substrate to the ER in the first place (Erbay et al., 2009) , ER is protected from stress and dysfunction with favorable organismic outcomes. Thus, it may be prudent to consider mechanisms for controlling ER homeostasis with a focus on the metabolic aspects of ER function, particularly through the control of lipids, and to exercise caution on enhancing insulin sensitivity or secretion to overcome insulin resistance without addressing underlying mechanisms impairing ER function and the whole organismal context, including the microbiota, within which such manipulations are conducted.
